The store will not work correctly when cookies are disabled.
2-(2-Oxo-2-(3,4,5-trimethoxyphenyl)ethyl)-9H-pyrido[3,4-b]indol-2-iumbromide
ID: ALA4101432
PubChem CID: 137658680
Max Phase: Preclinical
Molecular Formula: C22H21BrN2O4
Molecular Weight: 377.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(C(=O)C[n+]2ccc3c(c2)[nH]c2ccccc23)cc(OC)c1OC.[Br-]
Standard InChI: InChI=1S/C22H20N2O4.BrH/c1-26-20-10-14(11-21(27-2)22(20)28-3)19(25)13-24-9-8-16-15-6-4-5-7-17(15)23-18(16)12-24;/h4-12H,13H2,1-3H3;1H
Standard InChI Key: FAKQBKNKOVTQTI-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
19.4759 -4.1839 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
15.6127 -2.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3313 -3.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8638 -3.6321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4220 -2.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9563 -2.7039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6793 -3.4872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3388 -3.9926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7868 -2.7253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0213 -3.5201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8254 -3.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3957 -3.1119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1564 -2.3152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3528 -2.1261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1980 -3.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7646 -2.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5670 -2.8945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5288 -1.9132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7969 -3.6839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5984 -3.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1658 -3.2753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9263 -2.4817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1253 -2.2942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9685 -3.4652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2053 -4.2552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4908 -1.8802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2938 -2.0685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8338 -4.6655 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6360 -4.8568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 10 1 0
9 6 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
21 24 1 0
24 25 1 0
22 26 1 0
26 27 1 0
20 28 1 0
28 29 1 0
M CHG 2 1 -1 12 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 377.42 | Molecular Weight (Monoisotopic): 377.1496 | AlogP: 3.52 | #Rotatable Bonds: 6 |
Polar Surface Area: 64.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.17 | CX Basic pKa: ┄ | CX LogP: -1.31 | CX LogD: -1.31 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.41 | Np Likeness Score: 0.20 |
References
1. Venkataramana Reddy PO, Mishra S, Tantak MP, Nikhil K, Sadana R, Shah K, Kumar D.. (2017) Design, synthesis and in vitro cytotoxicity studies of novel β-carbolinium bromides., 27 (6): [PMID:28254167] [10.1016/j.bmcl.2017.02.010] |